[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Praxis Precision Medicines, Inc. Common Stock (PRAX)
Praxis Precision Medicines (PRAX) surges on positive FDA alignment for Elsunersen and strong clinical trial results, hitting a 52-week high. Analysts issue price target upgrades, signaling significant growth potential.
About Praxis Precision Medicines, Inc. Common Stock
Praxis Precision Medicines, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders.
Praxis Precision Medicines, Inc. Common Stock uses the ticker $PRAX for trading. Listed in the Stocks category.
Insights
- Praxis Precision Medicines, Inc. Common Stock (PRAX) sentiment near a 52-week high at XX.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) trading volume is up XXXXXX% from the previous week.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) market cap is up XXXX% from the previous month.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) social dominance is up XXXXXX% from the previous X months.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) Galaxy Score™ is up XXXXX% from the previous week.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) sentiment is up XXXXXX% from the previous X months.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) creators is up XXXXXX% from the previous week.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) engagements is up XXXXXX% from the previous week.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) mentions is up XXXXXX% from the previous week.
- Praxis Precision Medicines, Inc. Common Stock (PRAX) posts created is up 2100% from the previous week.
- Praxis Precision Medicines, Inc. Common Stock Price hit a 52-Week high of $XXXXXX for the hour
Price: $XXXXXX
Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week high, driven by positive news regarding FDA meetings and successful clinical trial results, indicating strong positive momentum and potential short squeezes.
24-Hour: XXXX% 7-Day: XXXXX% 30-Day: XXXXX%
1-Year High: $XXX on 2025-12-08
1-Year Low: $XXXXX on 2025-04-10
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Praxis Precision Medicines, Inc. Common Stock (PRAX) is currently AltRank #384 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +287
X Month: XXX +273
1-Year High: XXXXX on 2025-11-10
1-Year Low: XX on 2025-12-08
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +8
X Month: XX -XX
1-Year High: XX on 2025-12-05
1-Year Low: XX on 2025-11-02
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXXX +419%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +268%
X Year: XXXXXXXXX +250%
1-Year High: XXXXXXX on 2025-10-16
1-Year Low: XXX on 2025-06-15
Engagements by network (24h): Reddit: X X: XXXXX YouTube: X
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +109%
X Month: XXXXX -XX%
X Months: XXXXX +949%
X Year: XXXXX +1,041%
1-Year High: XXXXX on 2025-10-17
1-Year Low: X on 2025-09-13
Mentions by network (24h): Reddit: X X: XXX YouTube: X
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Praxis Precision Medicines, Inc. Common Stock (PRAX) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
X Week: XXX +166%
X Month: XXX -XX%
X Months: XXXXX +1,099%
X Year: XXXXX +1,084%
1-Year High: XXXXX on 2025-10-17
1-Year Low: X on 2025-09-13
The most influential creators that mention Praxis Precision Medicines, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @MarketCap_Live | X | XXX | X | XXXXX |
| @CulperResearch | X | XXXXXX | X | XXX |
| @Biobeats99 | X | XXX | X | XXX |
| @SteveDJacobs | X | XXXXX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @seedy19tron | X | XXXXX | X | XXX |
| @Quantumup1 | X | XXXXX | X | XX |
| @TENETTRADEGROUP | X | XXXXXX | X | XX |
| @linhnguyen64143 | X | XX | X | XX |
| @MarcJacksonLA | XX | XXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +29%
X Month: XXX% +33%
X Months: XXX% +67%
X Year: XXX% +21%
1-Year High: XXX% on 2024-12-25
1-Year Low: XX% on 2025-10-12
Most Supportive Themes:
- Biotech Stock Catalyst Watchlists: (40%) Mentions of PRAX in the context of biotech stock catalyst watchlists, particularly focusing on upcoming Ph2 and Ph3 readouts.
- Trading Strategies and Catalysts: (35%) Posts discussing PRAX alongside other stocks, often related to trading strategies, options, and potential catalysts.
Most Critical Themes:
- M&A Activity and Market Analysis: (25%) Mentions of PRAX in the context of M&A activity and market analysis, including comparisons to other companies.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.013%
X Month: XXXXX% +0.0077%
X Months: XXXXX% +0.014%
X Year: XXXXX% +0.0041%
1-Year High: XXXXX% on 2025-10-17
1-Year Low: XXXXX% on 2025-09-13
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-12-08
1-Year Low: XXXXXXX% on 2025-12-11
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$38%
X Month: $XXXXXXXXXXXXX +$48%
1-Year High: $XXXXXXXXXXXXX on 2025-12-08
1-Year Low: $XXXXXXXXXXXXX on 2025-10-06
Top Praxis Precision Medicines, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$PRAX +2.01% today as Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026 More Info:"
X Link @OzmosiHealth 2025-12-11T17:37Z 3014 followers, XXX engagements
"$SMX never forget👇🏆 $TGL $RETO $AXIL $BTTC $PETS $DHIL $BBGI $BDRX $ASPC $PLAB $CHOW $AFJK $SMX $SOXS $BQ $JZXN $GEMI $BEAT $IRBT $ONDS $BYND $ASST $TSLA $AAPL $META $MSFT $GOOGL $PLTR $NVDA $DJT $BTC $ETH $XRP $DOGE $SPY $QQQ $SPY $AMC $GME $OPEN $POM $NXDR $GRAN $IHRT $YGMZ"
X Link @dbr_says 2025-12-11T16:15Z 1803 followers, XXX engagements
"GIPR🚨 Setting up for a parabolic move. Now is the time to get in and not chase later.🚀 $TGL $SMX $WHLR $GURE $DBRG $TORO $TDIC $LICN $SPHL $ALMS $WAI $SOBR $PRAX $RIME $ZSPC $BBGI $CMND $OXM $PAPL $CREV $NVVE $SKIL $ASPC $BEAT $HSPO $JMG $URG $TE $ORCL $ESHA $CV $GRI $CHOW"
X Link @EpicRockets 2025-12-11T14:28Z XXX followers, XXX engagements
"Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026"
Reddit Link @Quantisnow 2025-12-11T13:57Z X followers, X engagements